GlaxoSmithKline (GSK) stock forecast for 2025. Forecast tables and graphs.

GlaxoSmithKline (GSK) stock forecast for 2025

The forecast has been updated: June 23, 2021 14:08


GlaxoSmithKline stock price online today

Analyst Target Price

49.17

Dividend Date

08.07.2021

Ex Dividend Date

20.05.2021

Last Split Factor

2:1

Last Split Date

12.11.1991

Should you buy or sell GlaxoSmithKline stock stock today? What is the projected target price level for 2025? How much will it cost in 2025? GlaxoSmithKline stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2025.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $49.17 target price for GlaxoSmithKline stock stock.

Today 200 Day Moving Average is the support level (37.2146 $).

50 Day Moving Average is the resistance level (39.01 $).




GSK Forecast for 2025

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 44.39 43.94 45.52 3.46 %
Feb 44.53 43.51 45.30 3.95 %
Mar 46.04 45.67 46.82 2.45 %
Apr 45.22 44.56 46.08 3.29 %
May 46.42 45.69 47.27 3.33 %
Jun 46.07 44.63 47.49 6.02 %
Jul 45.25 44.35 46.30 4.23 %
Aug 44.89 44.12 45.33 2.67 %
Sep 44.86 43.70 45.87 4.73 %
Oct 43.51 42.39 44.41 4.55 %
Nov 43.51 42.48 43.87 3.17 %
Dec 42.85 42.28 43.38 2.54 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of GlaxoSmithKline stock.


GlaxoSmithKline overview

GlaxoSmithKline Address

980 GREAT WEST ROAD, BRENTFORD MIDDLESEX, GB

Market Capitalization

98 315 509 760 $

EBITDA

9 715 999 744

PE Ratio

13.6072

PEG Ratio

4.8231

Dividend Per Share

0.8

Dividend Yield

0.0201

EPS

2.872

Quarterly Earnings Growth YOY

-0.317

Quarterly Revenue Growth YOY

-0.184

Trailing PE

13.6072

Forward PE

14.8588

EV To Revenue

4.0656

EV To EBITDA

13.1876

52 Week High

41.44

52 Week Low

31.82

50 Day Moving Average

39.01

200 Day Moving Average

37.2146

Shares Outstanding

2515749888

Shares Float

2445716550

Shares Short Prior Month

24921522

Short Ratio

5.36

Percent Insiders

0.013

Percent Institutions

12.634

GlaxoSmithKline stock forecast for this year


GlaxoSmithKline stock forecast for Jan 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 44.39. Positive monthly dynamics of the instrument is expected with 3.461% volatility is expected.

Pessimistic forecast: 43.94

Optimistic: 45.52


GlaxoSmithKline stock forecast for Feb 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 44.53. Positive monthly dynamics of the instrument is expected with 3.949% volatility is expected.

Pessimistic forecast: 43.51

Optimistic: 45.30


GlaxoSmithKline stock forecast for Mar 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 46.04. Positive monthly dynamics of the instrument is expected with 2.455% volatility is expected.

Pessimistic forecast: 45.67

Optimistic: 46.82


GlaxoSmithKline stock forecast for Apr 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 45.22. Negative monthly dynamics of the instrument is expected with 3.291% volatility is expected.

Pessimistic forecast: 44.56

Optimistic: 46.08


GlaxoSmithKline stock forecast for May 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 46.42. Positive monthly dynamics of the instrument is expected with 3.332% volatility is expected.

Pessimistic forecast: 45.69

Optimistic: 47.27


GlaxoSmithKline stock forecast for Jun 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 46.07. Negative monthly dynamics of the instrument is expected with 6.016% volatility is expected.

Pessimistic forecast: 44.63

Optimistic: 47.49


GlaxoSmithKline stock forecast for Jul 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 45.25. Negative monthly dynamics of the instrument is expected with 4.230% volatility is expected.

Pessimistic forecast: 44.35

Optimistic: 46.30


GlaxoSmithKline stock forecast for Aug 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 44.89. Negative monthly dynamics of the instrument is expected with 2.665% volatility is expected.

Pessimistic forecast: 44.12

Optimistic: 45.33


GlaxoSmithKline stock forecast for Sep 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 44.86. Negative monthly dynamics of the instrument is expected with 4.729% volatility is expected.

Pessimistic forecast: 43.70

Optimistic: 45.87


GlaxoSmithKline stock forecast for Oct 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 43.51. Negative monthly dynamics of the instrument is expected with 4.547% volatility is expected.

Pessimistic forecast: 42.39

Optimistic: 44.41


GlaxoSmithKline stock forecast for Nov 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 43.51. Negative monthly dynamics of the instrument is expected with 3.172% volatility is expected.

Pessimistic forecast: 42.48

Optimistic: 43.87


GlaxoSmithKline stock forecast for Dec 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 42.85. Negative monthly dynamics of the instrument is expected with 2.542% volatility is expected.

Pessimistic forecast: 42.28

Optimistic: 43.38



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 111.7 (24.06.2021) 0.78 %
AbbVie Inc.
ABBV 114.74 (24.06.2021) 0.65 %
Aeterna Zentaris Inc.
AEZS 0.9101 (23.06.2021) 4.01 %
Allakos Inc.
ALLK 91.24 (23.06.2021) 0.55 %
Allogene Therapeutics, Inc.
ALLO 23.49 (23.06.2021) -1.92 %
Amgen Inc.
AMGN 240.95 (24.06.2021) 0.94 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 15.5 (23.06.2021) -0.70 %
Aurora Cannabis Inc.
ACB 9.02 (23.06.2021) 1.23 %
Becton Dickinson and Company
BDX 239.82 (24.06.2021) -0.17 %
Biogen Inc.
BIIB 349.16 (24.06.2021) -6.11 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 97.27 (24.06.2021) -0.46 %
BioNTech SE
BNTX 227.79 (24.06.2021) -0.75 %
bluebird bio, Inc.
BLUE 32.37 (23.06.2021) -1.25 %
Boston Scientific Corp.
BSX 43.71 (24.06.2021) -0.18 %
Bristol-Myers Squibb Company
BMY 65.85 (24.06.2021) 0.90 %
Canopy Growth Corp.
CGC 23.57 (23.06.2021) 0.86 %
Castle Biosciences, Inc.
CSTL 75.09 (24.06.2021) 0.55 %
Eli Lilly and Company
LLY 232.97 (24.06.2021) 7.31 %
Emergent BioSolutions Inc.
EBS 61.85 (24.06.2021) 3.00 %
Exelixis, Inc.
EXEL 22.86 (24.06.2021) 2.88 %
G1 Therapeutics, Inc.
GTHX 21.84 (23.06.2021) 2.25 %
Gilead Sciences, Inc.
GILD 66.65 (23.06.2021) -0.60 %
GlaxoSmithKline plc
GSK 39.85 (23.06.2021) 1.97 %
GoodRx Holdings, Inc.
GDRX 38.24 (23.06.2021) 1.30 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 86.13 (24.06.2021) 1.17 %
Inovio Pharmaceuticals, Inc.
INO 8.89 (24.06.2021) 2.30 %
Johnson & Johnson
JNJ 163.37 (24.06.2021) 0.46 %
Medtronic plc.
MDT 125.09 (24.06.2021) -0.32 %
Merck & Co., Inc.
MRK 76.36 (24.06.2021) 1.03 %
Moderna, Inc.
MRNA 212.04 (23.06.2021) -4.21 %
Novartis AG
NVS 92.39 (23.06.2021) -0.79 %
Novavax, Inc.
NVAX 192.24 (23.06.2021) -1.10 %
ObsEva SA
OBSV 3.01 (23.06.2021) 2.38 %
OrganiGram Holdings Inc.
OGI 3.07 (24.06.2021) 3.37 %
Pfizer Inc.
PFE 39.19 (24.06.2021) 0.36 %
Regeneron Pharmaceuticals, Inc.
REGN 544.45 (24.06.2021) 2.77 %
Sanofi
SNY 52.08 (23.06.2021) -0.42 %
Schrodinger, Inc.
SDGR 78.46 (24.06.2021) 2.07 %
Senseonics Holdings, Inc.
SENS 3.59 (23.06.2021) 3.16 %
Sorrento Therapeutics, Inc.
SRNE 9.04 (23.06.2021) 1.23 %
Stryker Corp.
SYK 261.39 (24.06.2021) -0.48 %
Sundial Growers Inc.
SNDL 1 (24.06.2021) 0.00 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 10.42 (24.06.2021) 2.16 %
Thermo Fisher Scientific Inc.
TMO 495.36 (24.06.2021) 0.27 %
Tilray, Inc.
TLRY 18.26 (24.06.2021) 3.69 %
UnitedHealth Group, Inc.
UNH 398.87 (24.06.2021) 0.84 %
Veeva Systems Inc.
VEEV 312 (24.06.2021) 0.28 %
Zomedica Corp.
ZOM 0.8401 (24.06.2021) -0.88 %
Zynerba Pharmaceuticals, Inc.
ZYNE 5.77 (24.06.2021) 3.59 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.